Recruiting
Phase 3

Amyloid Removal

Sponsor:

Washington University School of Medicine

Code:

NCT06384573

Conditions

Alzheimer's Disease

Dementia

Alzheimer's Disease, Familial

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

lecanemab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Washington University School of Medicine on 2025-04-03.